PHARMACEUTICAL COMPOSITIONS FOR ALLEVIATING POST- MENOPAUSAL SYMPTOMS COMPRISING MELATONIN AND A LEAST ONE ESTROGEN AND/OR ANDROGEN

• 1. 褪黑激素和褪黑激素能配体在获得用于预防或治疗胃肠系统疾病的药物组合物中的应用 [P] . 中国专利： CN1283455A . 2001-02-14
• 2. 促进体内分泌褪黑激素的药物以及相关中药组合物的应用 [P] . 中国专利： CN1724036A . 2006-01-25
• 3. Pharmaceutical compositions for alleviating post-menopausal symptoms comprising melatonin and a least one estrogen and/ or androgen [P] . IL96926A . 1996-01-19

  机译： 用于缓解绝经后症状的药物组合物，其包含褪黑激素和至少一种雌激素和/或雄激素

• 4. COMPOSITIONS FOR ALLEVIATING POST-MENOPAUSAL SYMPTOMS COMPRISING MELATONIN AND LEAST ONE ESTROGEN AND/OR ANDROGEN [P] . IL96926D0 . 1992-03-29

  机译： 用于缓解绝经后症状的组合物，其包含褪黑激素和至少一种雌激素和/或雄激素

• 5. COMPOSITION FOR ALLEVIATING MENOPAUSAL SYMPTOMS COMPRISING MELATONIN AND AN ESTROGEN AND/OR AN ANDROGEN. [P] . NZ236755A . 1994-09-27

  机译： 缓解褪黑素症状的组合物，其包含褪黑激素和雌激素和/或雄激素。

• 1. Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS) [O] . Dahima Cintron, Brian D. Lahr, Kent R. Bailey, -1
• 2. British Menopause Society consensus statement on the management of estrogen deficiency symptoms, arthralgia and menopause diagnosis in women treated for early breast cancer [O] . Jo Marsden, Mike Marsh, Anne Rigg 2019

• 1. 褪黑激素是一种前景看好的临床药物及抗衰老食品 [C] . 孙素波 . 第九届全国老年药学抗衰老医药保健学术年会 . 1996
• 2. 孕期褪黑激素和雌激素对胰岛素释放的影响 [A] . 张若栩 . 2019